Clinical trial
POEM a Novel Endoscopic Treatment for Achalasia
NCT01512719 is registered in ClinicalTrials.gov with Hadassah Medical Organization as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- POEM a Novel Endoscopic Treatment for Achalasia
- Lead sponsor
- Hadassah Medical Organization
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- January 31, 2013
- Completion date
- January 31, 2023
- Enrollment
- 100 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
achalasia